Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-047429
Filing Date
2023-08-25
Accepted
2023-08-25 18:37:56
Documents
1
Period of Report
2023-08-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 37677
  Complete submission text file 0001209191-23-047429.txt   39126
Mailing Address 900 INDUSTRIAL ROAD, SUITE C SAN CARLOS CA 94070
Business Address 900 INDUSTRIAL ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Issuer) CIK: 0001814140 (see all company filings)

EIN.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O APEXIGEN, INC 75 SHOREWAY SAN CARLOS CA 94070
Business Address
Yang Xiaodong (Reporting) CIK: 0001940817 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39488 | Film No.: 231209683